🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Analgesic Effect of Accelerated Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain

RecruitingNAAges 18 Years - anyAllJakub Antczak
NCT05295498 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Peripheral neuropathy is a frequent condition, commonly associated with pain. Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive method of modulation of brain plasticity and is regarded as one of alternative methods to alleviate pain associated with various kind of neuropathies. rTMS is usually performed once a day and the whole therapy of neuropathic pain lasts one week. In a number of recent clinical trials including patients with depression and some other disorders, rTMS was delivered several times a day, which reduced the time of the whole therapy. This approach was termed an accelerated rTMS. The purpose of this study is to investigate feasibility of accelerated rTMS in treatment of neuropathic pain.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of peripheral neuropathy * Neuropathic pain of constant severity since not less than a month and requiring use of analgesics more than once a week * Score of 30 millimeter or more on the 100 millimeter visual analog scale of pain intensity at inclusion Exclusion Criteria: * Severe depression * Personality disorders and other psychiatric conditions, which could disturb the participation in the study * Cognitive deficits, which could disturb the participation in the study * Epilepsy * Presence of magnetic material in the reach of magnetic field * Pregnancy * Likelihood to get pregnant * Intracranial electrodes
💊

What it tests

  • Active repetitive transcranial magnetic stimulation
  • Sham repetitive transcranial magnetic stimulation
📍

Where

1 site
Jagiellonian University Medical College
Krakow, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy